259 filings
Page 3 of 13
8-K
2fan7ijdmzcwpr7 m9ba
6 May 21
Other Events
10:12am
8-K
jm4h9090 303goey1j
15 Mar 21
Breakthrough Patent-pending Tracer Developed for Broad Use
10:39am
N-CEN
giumkun5
15 Mar 21
Annual report (registered investment company)
6:07am
N-CSR
4bsjwn6pd2 qdx
25 Feb 21
Certified annual shareholder report (management investment company)
5:26pm
8-K
b4xw84k
5 Oct 20
Other Events
9:03am
S-8
inuh12nbns 23ol4dibh
16 Sep 20
Registration of securities for employees
4:48pm
N-PX
yc2mch7b477cobqnco0
1 Sep 20
Annual report of proxy voting record
12:00am
N-CSRS
e7p qsmyu7
21 Aug 20
Certified semi-annual shareholder report (management investment company)
5:23pm
8-K
7q5ukn3mbwf9l57xt
21 Jul 20
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
8:43am
8-K
koklt s6petju9n
16 Jul 20
Daxor Announces Prospective Randomized Control Trial at Duke University Medical Center to Guide Volume Treatment In Heart Failure Patients
9:02am
8-K
egk2kweddi66ccko e7
15 Jul 20
Daxor Announces Initiation of First-of-It’s-Kind Multicenter BVA-100® Study in Hospitalized Patients with COVID-19
3:53pm
EFFECT
oumxgnhal
15 Jul 20
Notice of effectiveness
12:15am
CORRESP
0h37zc5c
13 Jul 20
Correspondence with SEC
12:00am
8-K
v3lapqf8bqsq
1 Jul 20
Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company’s Board of Directors
4:49pm
8-K
seeparvsg
6 May 20
Other Events
5:07pm
8-K
5lj0i6urj
23 Apr 20
Other Events
5:12pm
N-CEN
i36pclt
13 Mar 20
Annual report (registered investment company)
5:28pm
N-CSR
uzye4g0x
28 Feb 20
Certified annual shareholder report (management investment company)
5:05pm